Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

NCT00018031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C
HIV Infections

Interventions

DRUG: Peginterferon alfa-2b
DRUG: Ribavirin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)